Log in to your Inderes Free account to see all free content on this page.
Isofol Medical
0.68 SEK
+1.87 %
Less than 1K followers
ISOFOL
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Isofol Medical
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| EBITDA | -11.7 | -13.7 | -47.2 | -14.1 | -15.0 | -13.6 | -13.3 | -56.0 |
| EBIT | -11.7 | -13.7 | -47.2 | -14.1 | -15.0 | -13.6 | -13.3 | -56.0 |
| EBIT-% | ||||||||
| Profit before taxes | -10.9 | -13.1 | -43.5 | -13.7 | -14.7 | -13.1 | -12.8 | -54.2 |
| Net income | -10.9 | -13.1 | -43.5 | -13.7 | -14.7 | -13.1 | -12.8 | -54.2 |
Login required
This content is only available for logged in users